EUVIMEDEUVIMED entdecken
Open Access

Provider Specialization in Inflammatory Bowel Diseases: Quality of Care and Outcomes

James D Lewis, Colleen M Brensinger, Lauren E Parlett, Andres Hurtado-Lorenzo, Michael D Kappelman

Clinical Gastroenterology and Hepatology · 2024

DOI: 10.1016/j.cgh.2024.05.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von James D Lewis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatisti…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Quality of Health Care. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCCDPHP CDC HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Management of inflammatory bowel diseases (IBD) is complex and variation in care has been well-documented. However, the drivers of practice variation remain unexplored. We examined variation based on the treating gastroenterologist's IBD focus (proportion of outpatient visits for IBD). METHODS: We conducted a retrospective cohort of newly diagnosed patients with IBD using data from Optum's deidentified Clinformatics Data Mart Database (2000-2020). The exposure variable was whether the treating gastroenterologist had an IBD focus (>90th percentile of IBD visits/total outpatient visits). We used adjusted regression models to evaluate associations between provider IBD focus and process measures (use of mesalamine, corticosteroid, biologic, and narcotic medications and endoscopic or radiographic imaging) and clinical outcomes (time to IBD-related hospitalization and bowel resection surgery). We tested for change in treatment patterns over time by including an interaction term for study era (2004-2012 vs 2013-2020). RESULTS: The study included 772 children treated by 493 providers and 2864 adults treated by 2076 providers. In children, none of the associations between provider focus and process or outcome measures were significant. In adults, care from an IBD-focused provider was associated with more use of biologics, combination therapy, and imaging and endoscopy, and less mesalamine use for Crohn's disease (P < .05 for all comparisons) but not with other process measures. Biologics were prescribed more frequently and narcotics less frequently during the later era (P < .05 for both). Hospitalization and surgery rates were not associated with IBD focus or era. CONCLUSIONS: IBD care for adults varies by provider specialization. Given the evolving complexity, novel methods may be needed to standardize care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesQuality of Health CareHumansMaleFemaleRetrospective StudiesAdultChildAdolescentMiddle AgedYoung AdultPractice Patterns, Physicians'Treatment OutcomeGastroenterologyAgedSpecialization

Stichwörter der Autor:innen

Biologic TherapyCrohn’s DiseaseNarcoticsPractice VolumeSteroidsUlcerative Colitis

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelp…
  • Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Carelon Research, Inc, Wilmington, Delaware.
  • Research Department, Crohn's & Colitis Foundation, New York, New York.
  • Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Förderung

  • NIDDK NIH HHS
  • NCCDPHP CDC HHS
  • NCATS NIH HHS
  • Centers for Disease Control and Prevention
  • National Institutes of Health

Zitieren

APA

Lewis, J. D., Brensinger, C. M., Parlett, L. E., Hurtado-Lorenzo, A., & Kappelman, M. D. (2024). Provider Specialization in Inflammatory Bowel Diseases: Quality of Care and Outcomes. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.05.024

Vancouver

Lewis JD, Brensinger CM, Parlett LE, Hurtado-Lorenzo A, Kappelman MD. Provider Specialization in Inflammatory Bowel Diseases: Quality of Care and Outcomes. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2024.05.024

BibTeX
@article{Lewis2024,
  author = {Lewis, James D and Brensinger, Colleen M and Parlett, Lauren E and Hurtado-Lorenzo, Andres and Kappelman, Michael D},
  title = {Provider Specialization in Inflammatory Bowel Diseases: Quality of Care and Outcomes},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1016/j.cgh.2024.05.024}
}
Kostenlos starten →